Molecular docking and dynamics approach to in silico drug repurposing for inflammatory bowels disease by targeting TNF alpha

References

• Akbar, S., Das, S., Iqubal, A., & Ahmed, B. (2021). Synthesis, biological evaluation and molecular dynamics studies of oxadiazine derivatives as potential anti-hepatotoxic agents. Journal of Biomolecular Structure and Dynamics, 22(11), 1–18. https://doi.org/10.1080/07391102.2021.1938233
   Google Scholar
• Argollo, M., Fiorino, G., Hindryckx, P., Peyrin-Biroulet, L., & Danese, S. (2017). Novel therapeutic targets for inflammatory bowel disease. Journal of Autoimmunity, 85, 103–116. https://doi.org/10.1016/j.jaut.2017.07.004
   PubMed Web of Science ®Google Scholar
• Baeyens, K. J., De Bondt, H. L., Raeymaekers, A., Fiers, W., & De Ranter, C. J. (1999). The structure of mouse tumour-necrosis factor at 1.4 A resolution: towards modulation of its selectivity and trimerization. Acta Crystallographica. Section D, Biological Crystallography, 55(Pt 4), 772–778. https://doi.org/10.1107/s0907444998018435
   PubMedGoogle Scholar
• Bai, L., Scott, M. K. D., Steinberg, E., Kalesinskas, L., Habtezion, A., Shah, N. H., & Khatri, P. (2021). Computational drug repositioning of atorvastatin for ulcerative colitis. Journal of the American Medical Informatics Association: JAMIA, 28(11), 2325–2335. https://doi.org/10.1093/jamia/ocab165
   PubMed Web of Science ®Google Scholar
• Brittenham, G. M., Griffith, P. M., Nienhuis, A. W., McLaren, C. E., Young, N. S., Tucker, E. E., Allen, C. J., Farrell, D. E., & Harris, J. W. (1994). Efficacy of deferoxamine in preventing complications of iron overload in patients with Thalassemia major. New England Journal of Medicine, 331(9), 567–573. https://doi.org/10.1056/NEJM199409013310902
   PubMed Web of Science ®Google Scholar
• Brunton, L. L., Parker, K. L., Blumenthal, D. K., & Buxton, I. L. O. (2008). Goodman & Gilman’s manual of pharmacology and therapeutics. The McGraw-Hill Companies, Inc, 1(1), 132–134.https://doi.org/10.1036/0071443436
   Google Scholar
• Chandel, V., Raj, S., Rathi, B., & Kumar, D. (2020). In silico identification of potent fda approved drugs against coronavirus covid-19 main protease: A drug repurposing approach. Chemical Biology Letters, 7(3), 166–175.
   Web of Science ®Google Scholar
• Chen, I. J., & Foloppe, N. (2010). Drug-like bioactive structures and conformational coverage with the ligprep/confgen suite: Comparison to programs MOE and catalyst. Journal of Chemical Information and Modeling, 50(5), 822–839. https://doi.org/10.1021/ci100026x
   PubMed Web of Science ®Google Scholar
• David, T. I., Adelakun, N. S., Omotuyi, O. I., Metibemu, D. S., Ekun, O. E., Eniafe, G. O., Inyang, O. K., Adewumi, B., Enejoh, O. A., Owolabi, R. T., & Oribamise, E. I. (2018). Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR. Bioinformation, 14(9), 574–579. https://doi.org/10.6026/97320630014574
   PubMed Web of Science ®Google Scholar
• Desmond | Schrödinger. (n.d.). Retrieved July 23, 2021, from https://www.schrodinger.com/products/desmond
   Google Scholar
• Devereux, M., & Popelier, P. L. A. (2010). In silico techniques for the identification of bioisosteric replacements for drug design. Current Topics in Medicinal Chemistry, 10(6), 657–668. https://doi.org/10.2174/156802610791111470
   PubMed Web of Science ®Google Scholar
• Dhinesh Kumar, T., & Velmurugan, D. (2013). Molecular docking studies on inhibition of human kynurenine aminotransferase-1 for treating schizophrenia disorder. Star Bio. Info, 1.
   Google Scholar
• Fiers, W. (1991). Tumor necrosis factor Characterization at the molecular, cellular and in vivo level. FEBS Letters, 285(2), 199–212. https://doi.org/10.1016/0014-5793(91)80803-B
   PubMed Web of Science ®Google Scholar
• Gorla, U. S., Gsn, K. R., Kulandaivelu, U., Alavala, R. R., Das, S., & Joseph, A. (2021). Bioflavonoids as potential target inhibitors in COVID-19: An in silico analysis. Journal of Research in Pharmacy, 25(6), 982–997. https://doi.org/10.29228/jrp.94
   Web of Science ®Google Scholar
• Grenier, L., & Hu, P. (2019). Computational drug repurposing for inflammatory bowel disease using genetic information. Computational and Structural Biotechnology Journal, 17, 127–135. https://doi.org/10.1016/j.csbj.2019.01.001
   PubMed Web of Science ®Google Scholar
• Han, L., Sayyid, Z. N., & Altman, R. B. (2021). Modeling drug response using network-based personalized treatment prediction (NetPTP) with applications to inflammatory bowel disease. PLOS Computational Biology, 17(2), e1008631–19. https://doi.org/10.1371/journal.pcbi.1008631
   PubMed Web of Science ®Google Scholar
• He, M. M., Smith, A. S., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C., Fung, A. D., Farrington, G., Eldredge, J. K., Day, E. S., Cruz, L. A., Cachero, T. G., Miller, S. K., Friedman, J. E., Choong, I. C., & Cunningham, B. C. (2005). Small-molecule inhibition of TNF-alpha. Science (New York, NY), 310(5750), 1022–1025. https://doi.org/10.1126/science.1116304
   Google Scholar
• Hollenbach, E., Neumann, M., Vieth, M., Roessner, A., Malfertheiner, P., & Naumann, M. (2004). Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 18(13), 1550–1552. https://doi.org/10.1096/fj.04-1642fje
   PubMed Web of Science ®Google Scholar
• Idriss, H. T., & Naismith, J. H. (2000). TNF-α and the TNF receptor superfamily: Structure-function relationship(s). Microscopy Research and Technique, 50(3), 184–195. https://doi.org/10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H
   PubMed Web of Science ®Google Scholar
• Kwak, M. S., Lee, H. H., Cha, J. M., Shin, H. P., Jeon, J. W., & Yoon, J. Y. (2020). Novel candidate drugs in anti-tumor necrosis factor refractory Crohn’s diseases: in silico study for drug repositioning. Scientific Reports, 10(1), 1–9. https://doi.org/10.1038/s41598-020-67801-0
   PubMed Web of Science ®Google Scholar
• Liu, X., Fan, Y., Du, L., Mei, Z., & Fu, Y. (2021). In silico and in vivo studies on the mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the treatment of ulcerative colitis. Frontiers in Pharmacology, 12, 1489. https://doi.org/10.3389/fphar.2021.665102
   Web of Science ®Google Scholar
• Lloyd, K., Papoutsopoulou, S., Smith, E., Stegmaier, P., Bergey, F., Morris, L., Kittner, M., England, H., Spiller, D., White, M. H. R., Duckworth, C. A., Campbell, B. J., Poroikov, V., Martins dos Santos, V. A. P., Kel, A., Muller, W., Mark Pritchard, D., Probert, C., & Burkitt, M. D. (2020). Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease. DMM Disease Models and Mechanisms, 13(11), 1-12. https://doi.org/10.1242/DMM.044040
   Google Scholar
• Loddo, I., & Romano, C. (2015). Inflammatory bowel disease: Genetics, epigenetics, and pathogenesis. Frontiers in Immunology, 6, 1–6. https://doi.org/10.3389/fimmu.2015.00551
   PubMed Web of Science ®Google Scholar
• Loetscher, H., Gentz, R., Zulauf, M., Lustig, A., Tabuchi, H., Schlaeger, E. J., Brockhaus, M., Gallati, H., Manneberg, M., & Lesslauer, W. (1991). Recombinant 55-kDa tumor necrosis factor (TNF) receptor: Stiochiometry of binding to TNFα and TNFβ and inhibition of TNF activity. Journal of Biological Chemistry, 266(27), 18324–18329. https://doi.org/10.1016/S0021-9258(18)55273-X
   PubMed Web of Science ®Google Scholar
• Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• Mathpal, S., Joshi, T., Sharma, P., Joshi, T., Pundir, H., Pande, V., & Chandra, S. (2022). A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor. Journal of Biomolecular Structure & Dynamics, 40(3), 1084–1100. https://doi.org/10.1080/07391102.2020.1821785
   PubMed Web of Science ®Google Scholar
• Maurya, S. K., Maurya, A. K., Mishra, N., & Siddique, H. R. (2020). Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2. Journal of Receptor and Signal Transduction Research, 40(6), 605–612. https://doi.org/10.1080/10799893.2020.1772298
   PubMed Web of Science ®Google Scholar
• Mesbah-Uddin, M., Elango, R., Banaganapalli, B., Shaik, N. A., & Al-Abbasi, F. A. (2015). In-silico analysis of inflammatory bowel disease (IBD) GWAS loci to novel connections. PLoS One, 10(3), e0119420. https://doi.org/10.1371/journal.pone.0119420
   PubMed Web of Science ®Google Scholar
• Muetzel, W., & Speck, U. (1983). Pharmacochemical profile of iopromide. American Journal of Neuroradiology, 4(3), 350–352.
   PubMed Web of Science ®Google Scholar
• Niu, K., Li, Q., Liu, Y., Qiao, Y., Li, B., Wei, C., Wang, K., Cui, L., Zheng, C., Wang, R., Zhang, L., Zhang, H., Sun, B., & Yu, B. (2021). Molecular targets and mechanisms of scutellariae radix-Coptidis rhizoma drug pair for the treatment of ulcerative colitis based on network pharmacology and molecular docking. Evidence-Based Complementary and Alternative Medicine: eCAM, 2021, 9929093. https://doi.org/10.1155/2021/9929093
   PubMed Web of Science ®Google Scholar
• Ostade, X. V., Vandenabeele, P., Everaerdt, B., Loetscher, H., Gentz, R., Brockhaus, M., Lesslauer, W., Tavernier, J., Brouckaert, P., & Fiers, W. (1993). Human TNF mutants with selective activity on the p55 receptor. Nature, 361(6409), 266–269. https://doi.org/10.1038/361266a0
   PubMed Web of Science ®Google Scholar
• Peyvandipour, A., Saberian, N., Shafi, A., Donato, M., & Draghici, S. (2018). Systems biology: A novel computational approach for drug repurposing using systems biology. Bioinformatics (Oxford, England), 34(16), 2817–2825. https://doi.org/10.1093/bioinformatics/bty133
   PubMed Web of Science ®Google Scholar
• Raychaudhuri, R., Pandey, A., Das, S., Nannuri, S. H., Joseph, A., George, S. D., Vincent, A. P., & Mutalik, S. (2021). Nanoparticle impregnated self-supporting protein gel for enhanced reduction in oxidative stress: A molecular dynamics insight for lactoferrin-polyphenol interaction. International Journal of Biological Macromolecules, 189(August), 100–113. https://doi.org/10.1016/j.ijbiomac.2021.08.089
   PubMedGoogle Scholar
• Rostkowski, M., Olsson, M. H., Søndergaard, C. R., & Jensen, J. H. (2011). Graphical analysis of pH-dependent properties of proteins predicted using PROPKA. BMC Structural Biology, 11(1), 6. https://doi.org/10.1186/1472-6807-11-6[PMC][21269479
   PubMedGoogle Scholar
• Roy, S., & Dhaneshwar, S. (2018). Drug repurposing opportunities for inflammatory bowel disease, 1-7. MedDocs Publishers LLC. http://meddocsonline.org/.
   Google Scholar
• Roy, R., Sk, M. F., Jonniya, N. A., Poddar, S., & Kar, P. (2021). Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2021.1897680
   Google Scholar
• Sankhe, R., Rathi, E., Manandhar, S., Kumar, A., Pai, S. R. K., Kini, S. G., & Kishore, A. (2021). Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study. Journal of Molecular Structure, 1224, 129073. https://doi.org/10.1016/j.molstruc.2020.129073
   PubMed Web of Science ®Google Scholar
• Shivakumar, D., Williams, J., Wu, Y., Damm, W., Shelley, J., & Sherman, W. (2010). Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the opls force field. Journal of Chemical Theory and Computation, 6(5), 1509–1519. https://doi.org/10.1021/ct900587b
   PubMed Web of Science ®Google Scholar
• Somolinos, F. J., León, C., & Guerrero-Aspizua, S. (2021). Drug repurposing using biological networks. Processes, 9(6), 1057. https://doi.org/10.3390/pr9061057
   Web of Science ®Google Scholar
• Verma, P., Tiwari, M., & Tiwari, V. (2018). In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii. Journal of Biomolecular Structure & Dynamics, 36(5), 1182–1194. https://doi.org/10.1080/07391102.2017.1317025
   PubMed Web of Science ®Google Scholar
• Vulliemoz, M., Brand, S., Juillerat, P., Mottet, C., Ben-Horin, S., & Michetti, P., & on behalf of Swiss IBDnet, an official working group of the S. S. of G. (2020). TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update. Digestion, 101(Suppl. 1), 16–26. https://doi.org/10.1159/000506898
   PubMed Web of Science ®Google Scholar
• Zhang, Y. Z., & Li, Y. Y. (2014). Inflammatory bowel disease: Pathogenesis. World Journal of Gastroenterology, 20(1), 91–99. https://doi.org/10.3748/wjg.v20.i1.91
   PubMed Web of Science ®Google Scholar
• Zhong, H., Tran, L. M., & Stang, J. L. (2009). Induced-fit docking studies of the active and inactive states of protein tyrosine kinases. Journal of Molecular Graphics & Modelling, 28(4), 336–346. https://doi.org/10.1016/j.jmgm.2009.08.012
   PubMed Web of Science ®Google Scholar